Literature DB >> 30938821

Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report.

Hideaki Uchida1, Masahiro Kamata, Ayu Watanabe, Ai Agematsu, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada.   

Abstract

Entities:  

Keywords:  IL-13; IL-4; IL-4Rα; alopecia areata; dupilumab; atopic dermatitis

Year:  2019        PMID： 30938821     DOI： 10.2340/00015555-3183

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  5 in total

Review 1.  New and Emerging Therapies for Alopecia Areata.

Authors:  Aunna Pourang; Natasha Atanaskova Mesinkovska
Journal:  Drugs       Date:  2020-05       Impact factor: 9.546

2.  Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis.

Authors:  Maurizio Romagnuolo; Mauro Barbareschi; Simona Tavecchio; Luisa Angileri; Silvia Mariel Ferrucci
Journal:  Skin Appendage Disord       Date:  2021-07-27

3.  Long-Term Efficacy of Dupilumab in Alopecia Areata.

Authors:  Maansi Kulkarni; Craig A Rohan; Jeffrey B Travers; Rocco Serrao
Journal:  Am J Case Rep       Date:  2022-06-21

4.  Short communication: Comments on hair disorders associated with dupilumab based on VigiBase.

Authors:  Sunny Park; So Hyang Park; Young Joo Byun; Soo An Choi
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

5.  Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata.

Authors:  Reiko Kageyama; Taisuke Ito; Shiho Hanai; Naomi Morishita; Shinsuke Nakazawa; Toshiharu Fujiyama; Tetsuya Honda; Yoshiki Tokura
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.